Caffeine and Energy Drinks

Caffeine is the world's most consumed psychoactive substance — an adenosine-receptor antagonist delivering alertness, modest cognitive and physical performance gains, and dependence-with-withdrawal (headache, fatigue, irritability for a few days) that meets pharmacological criteria without the destructive profile of the drugs the word usually implies. The consensus safety lines are unusually clean: up to ~400 mg daily for healthy adults (roughly four brewed coffees) shows no consistent harm signal in the vast cohort literature — coffee drinking itself associates with neutral-to-favourable outcomes across cardiovascular, liver and neurodegenerative endpoints (association, healthy-user caveats, but decades deep); ~200 mg daily is the pregnancy guidance line; ~3 mg/kg as a single dose and daily bound is the European reference for children and adolescents — translating to very little headroom for a 40 kg twelve-year-old in a market selling 150-300 mg cans. Individual variation is real and partly genetic (CYP1A2 metabolism speed), anxiety and sleep sensitivity vary widely, and the practical toxicology begins where products concentrate the dose faster than warning systems evolved.

The controversy is not coffee — it is the product tiers built on caffeine's benign reputation. Energy drinks: 80-300 mg per can, engineered for palatability and speed (cold, sweet, chugged — versus hot coffee's built-in rate limiter), bundled with sugar loads and a halo of unproven co-ingredients (taurine, guarana — which is simply more caffeine, B-vitamin theatre), and marketed through gaming, extreme sports and influencer channels aimed squarely at adolescents. Shots and pre-workouts: 200-400+ mg per serving, sometimes stacked with other stimulants. Concentrated and pure forms: anhydrous caffeine powders and bulk liquids where a teaspoon can approach lethal range — the source of documented healthy-young-adult deaths that drove regulatory action against retail pure caffeine. Caffeinated everything: gums, bars, "charged" lemonades (the subject of wrongful-death litigation after cardiac events in vulnerable customers, and since discontinued) — caffeine appearing where consumers don't model it. The through-line: dose, rate, disclosure and audience — the four variables coffee culture self-regulated and the product economy optimised in the wrong direction.

Adolescents are the controversy's genuine core. Consumption: large minorities of teens use energy drinks regularly, with marketing exposure documented and effective. Evidence of harm: US poison centres logged 32,000+ paediatric caffeine-product exposures over a recent decade (most young children finding products; the serious outcomes concentrating in teenagers using intentionally — hospitalisation odds an order of magnitude higher in 13-19s), and the observational literature consistently associates adolescent energy-drink use with sleep disruption (the best-established harm — caffeine's half-life colliding with adolescent sleep biology), anxiety symptoms, cardiovascular complaints (palpitations, blood-pressure elevation), risk-behaviour clustering, and the alcohol-mixing problem: caffeine masking intoxication cues ("wide-awake drunk"), associated with higher consumption and harm — the combination regulators forced off the pre-mixed market years ago. Causality versus clustering is genuinely debated (energy-drink-using teens differ in many ways); sleep harm and acute cardiac events in susceptible individuals (undiagnosed arrhythmia syndromes above all) are the claims with the firmest footing — and sufficient for the policy conclusion most bodies reached: these products have no place in children's diets.

Regulation has moved from labelling to access. Several countries ban energy-drink sales to minors outright (Lithuania first, Latvia, Poland's 2024 under-18 ban among the notable recent additions), the UK moved to ban sales to under-16s in England after years of voluntary supermarket restrictions, and other jurisdictions run warning-label and school-ban regimes; the US remains lighter-touch — labelling conventions, litigation as de facto regulation (the charged-lemonade cases), and FDA action concentrated where deaths forced it (pure powdered caffeine). The policy logic mirrors this collection's tobacco-and-vaping files: an adult-legal stimulant product whose marketing and formulation target the age group least equipped to dose it, answered by age-gating rather than prohibition — with the honest caveats that enforcement varies, caffeine remains available in coffee anyway, and the co-load of sugar (a can often carries a day's added-sugar limit) would justify attention even if the caffeine didn't. Both trenches overreach on cue: industry's "coffee equivalence" defence ignores dose-rate-audience engineering; alarm content treating every palpitation as impending death ignores base rates. The calibrated middle is where the agencies landed.

For most adults the file is reassuring with footnotes. Performance: caffeine is one of the few legal ergogenic aids with genuine trial support (3-6 mg/kg improving endurance and power) — the sports-science literature is real, and so is the pre-workout sector's habit of stacking doses toward the tolerance ceiling. Cardiac: moderate intake does not cause hypertension or arrhythmia in the general population per the cohort weight; acute high doses raise blood pressure transiently and can trigger events in susceptible individuals — the emergency-department energy-drink case reports cluster around pre-existing (often undiagnosed) conditions, binge dosing and alcohol co-use. Sleep and anxiety: the underrated everyday harms — six-hour half-lives make afternoon dosing a stealth insomnia engine, and caffeine reliably worsens anxiety disorders at doses users rarely connect. Pregnancy: the ~200 mg line reflects association evidence on growth restriction; energy drinks are discouraged outright. Withdrawal and dependence: real, brief, manageable — taper rather than quit cold if headaches matter. The unifying adult rule: count total daily milligrams across all sources, front-load them, and treat any product that makes counting hard as the warning label it is.

Adults: up to ~400 mg daily is well supported — count everything (coffee ~80-120 mg, espresso ~60-80, tea ~30-50, cola ~30-40, energy drinks per label, pre-workout per scoop and honestly), stop by early afternoon if sleep matters, halve the maths in pregnancy (~200 mg), and route around energy drinks entirely if you have hypertension, arrhythmia, anxiety disorder or are mixing with alcohol — the mask-the-drunk effect is the combination's specific danger. Parents: the paediatric guidance is genuinely simple — energy drinks have no place for children and young adolescents (a single can can exceed a child's entire daily reference dose), the household levers are availability and modelling, and the conversation lever is sleep and sport performance, which teens care about, rather than abstract harm. Never keep concentrated caffeine powder in a home. Athletes: 3-6 mg/kg works; label-audited single-ingredient dosing beats proprietary stacks. And for reading the discourse: coffee's halo does not transfer to a 300 mg iced stack marketed by a streamer — and a palpitation after one latte is not a cardiology emergency. Dose, rate, audience: the whole topic in three words.